Trial Profile
A Novel Non-invasive Way to Measure Airway Epithelial Permeability in Human Subjects
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 01 Mar 2024
Price :
$35
*
At a glance
- Drugs Mannitol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited
- 02 Jan 2018 Status changed from recruiting to completed.
- 24 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.